company background image
688139 logo

Qingdao Haier BiomedicalLtd SHSE:688139 Stock Report

Last Price

CN¥36.93

Market Cap

CN¥11.7b

7D

12.6%

1Y

-46.5%

Updated

26 Apr, 2024

Data

Company Financials +

Qingdao Haier Biomedical Co.,Ltd

SHSE:688139 Stock Report

Market Cap: CN¥11.7b

688139 Stock Overview

Qingdao Haier Biomedical Co., Ltd engages in the design, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples worldwide.

688139 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Qingdao Haier Biomedical Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Qingdao Haier BiomedicalLtd
Historical stock prices
Current Share PriceCN¥36.93
52 Week HighCN¥73.49
52 Week LowCN¥25.50
Beta0.89
1 Month Change33.32%
3 Month Change13.42%
1 Year Change-46.51%
3 Year Change-62.75%
5 Year Changen/a
Change since IPO21.20%

Recent News & Updates

Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Apr 26
Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Apr 26
Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Recent updates

Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Apr 26
Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Apr 26
Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Shareholder Returns

688139CN Medical EquipmentCN Market
7D12.6%6.4%2.1%
1Y-46.5%-16.8%-14.2%

Return vs Industry: 688139 underperformed the CN Medical Equipment industry which returned -18.6% over the past year.

Return vs Market: 688139 underperformed the CN Market which returned -14.6% over the past year.

Price Volatility

Is 688139's price volatile compared to industry and market?
688139 volatility
688139 Average Weekly Movement8.5%
Medical Equipment Industry Average Movement8.1%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 688139's share price has been volatile over the past 3 months.

Volatility Over Time: 688139's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20052,636Zhanjie Liuwww.haierbiomedical.com

Qingdao Haier Biomedical Co., Ltd engages in the design, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples worldwide. The company offers automatic liquid handling workstations; active temperature controlled RKN Containers; biomedical, cryo, controlled rate, plasma, ULT, and vaccine freezers; blood bank, laboratory, pharmacy, and vaccine refrigerators; blood/fluid warming and biological safety cabinets; backup systems; clean bench and laminar flow products; centrifuge products; consumables; cold/freezer rooms; vertical autoclaves; health care solutions; incubators; fully-automated sample processing system; liquid nitrogen storage solutions; plasma apheresis systems; transport coolers; and vaccine safety solutions. It also provides blood, vaccine, reagent, sample, and laboratory network solutions in agri and animal health sectors.

Qingdao Haier Biomedical Co.,Ltd Fundamentals Summary

How do Qingdao Haier BiomedicalLtd's earnings and revenue compare to its market cap?
688139 fundamental statistics
Market capCN¥11.66b
Earnings (TTM)CN¥406.15m
Revenue (TTM)CN¥2.28b

28.7x

P/E Ratio

5.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688139 income statement (TTM)
RevenueCN¥2.28b
Cost of RevenueCN¥1.14b
Gross ProfitCN¥1.14b
Other ExpensesCN¥737.51m
EarningsCN¥406.15m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.29
Gross Margin50.14%
Net Profit Margin17.80%
Debt/Equity Ratio0.6%

How did 688139 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

40%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.